Noubar Afeyan, Director at Moderna, Inc. (MRNA), sold 21,600 shares at $122.69 ($2.7M) on 2024-06-26, disclosed to the SEC on 2024-06-28.
Scheduled sale ($2.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.69 | 2,460 | $302K | 11.0% |
| 2 | $122.69 | 2,460 | $302K | 11.0% |
| 3 | $123.74 | 1,600 | $198K | 7.2% |
| 4 | $124.90 | 1,500 | $187K | 6.8% |
| 5 | $125.71 | 1,100 | $138K | 5.0% |
| 6 | $127.50 | 1,100 |
| $140K |
| 5.1% |
| 7 | $128.78 | 1,435 | $185K | 6.7% |
| 8 | $128.78 | 1,435 | $185K | 6.7% |
| 9 | $129.84 | 2,300 | $299K | 10.9% |
| 10 | $130.76 | 2,705 | $354K | 12.9% |
| 11 | $130.76 | 2,705 | $354K | 12.9% |
| 12 | $131.56 | 700 | $92K | 3.4% |
| 13 | $134.05 | 100 | $13K | 0.5% |
| Total | $127.25 avg | 21,600 | $2.7M | 100% |
| Filing → |
| MRNA | SELL | 2025-12-15 | $1.4M | — | Filing → |
| MRNA | SELL | 2024-08-02 | $3.6M | — | Filing → |
| MRNA | SELL | 2024-07-26 | $2.9M | — | Filing → |